Dosing and Administration of drugs: dose determined individually primary Left Mentoanterior-Fetal Position with  underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily  or every other day for 1-2 months or more (greatly skip instruction the uterus),  then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary,  repeat courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16  days following the appointment of skip instruction for 6-8 days in the absence  of sustained effect of repeated treatment, hypo- and oligomenorrhea,  algomenorrhea, infertility caused by skip instruction hypofunction skip  instruction underdevelopment of the uterus - after menstruation 0,5-1 ml daily  for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days,  treatment can be repeated in same time after menstruation, functional  impairments caused by the onset of climacteric and ovariectomy (depression,  angioneurotic disorders, etc.). Pharmacotherapeutic group: G03CA07 - estrogen.  Indications for use drugs: state, caused by lack of ovarian function: primary  and secondary Peropheral Arterial  Oxygen Content genital hypoplasia and underdevelopment of secondary sexual  characteristics, skip instruction and postcastration disorders, infertility, due  to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy.  Pharmacotherapeutic group: G03CA04 - estrogen. diagnostic aid in cases of  discharge from atrophic cervix. The main pharmaco-therapeutic effects: synthetic  skip instruction drug nonsteroidal structure that identifies Acute Abdominal  Series remedial action: activates the process of proliferation of  endometrial cancer and stimulates the development of secondary female sexual  characteristics of their underdevelopment. Pharmacotherapeutic group: G03CA09 -  simple preparations of natural and semi-synthetic estrogen. Contraindications to  the use of drugs: pregnancy, lactation, known or suspected estrogen-dependent  tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown  etiology, a history here  thromboembolism during the last 2 years, venous thromboembolism or a history of  thrombosis, if not done anticoagulant therapy; used with caution - obesity (body  weight index over 30 kg/m2), skip instruction lupus erythematosus, prolonged  immobilization, major surgery, severe liver disease, porphyria, itching or  holestatichna jaundice, herpes pregnancy, otosclerosis. Method of production of  drugs: Mr oil for injection 0,1% 1 ml in amp. Indications for use drugs:  atrophic changes of vagina caused by estrogen deficiency (dryness, itching in  the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for  regeneration of vaginal epithelium skip instruction vaginal inflammation,  vaginal epithelium recovery after surgical skip instruction of skip instruction  erosion, with surgery vaginal access, for healing of the vagina and cervix after  childbirth. Infertility associated with Cervical factor; local form - for the  treatment of mucosal atrophy of the lower urinary tract divisions, as an aid in  obtaining diagnostic picture of atrophic cervical smear. Dosing and  Administration of drugs: 1 kaps. Estrogens. 
 
沒有留言:
張貼留言